Instituto RosenbuschBUE:ROSE -3.07%37 OCF Yield % is 5.94 as of Jul. 04, 2026, which is 29% below its 10-year median of 8.38. GuruFocus rates BUE:ROSE with a GF Score™ of 37/100 and a GF Value™ of ARS61.89 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Instituto Rosenbusch ranks better than 64.25% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Instituto Rosenbusch OCF Yield % Related Terms
Instituto Rosenbusch OCF Yield % Historical Data
* Premium members only.
The historical data trend for Instituto Rosenbusch's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BUE:ROSE vs ZTS, UTHR, VTRS: OCF Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Instituto Rosenbusch's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Instituto Rosenbusch OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Instituto Rosenbusch's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Instituto Rosenbusch's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Instituto Rosenbusch (BUE:ROSE) has a OCF Yield % of 5.94 as of Jul. 04, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Instituto Rosenbusch and its competitors. This is 29% below median its historical median of 8.38. According to the industry distribution chart, Instituto Rosenbusch ranks #360 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 35.7%.
Is Instituto Rosenbusch's OCF Yield % too high?
Instituto Rosenbusch's current OCF Yield % of 5.94 is 29% below median its 10-year median of 8.38. The Drug Manufacturers industry median OCF Yield % is 3.43. Instituto Rosenbusch's value of 5.94 is 73.2% above this industry median. Based on the distribution chart, Instituto Rosenbusch ranks #360 out of 1007 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Instituto Rosenbusch has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Instituto Rosenbusch's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Instituto Rosenbusch ranks #360 out of 1007 companies for OCF Yield %. This puts Instituto Rosenbusch in the upper half of its industry. The industry median OCF Yield % is 3.43. Instituto Rosenbusch's value of 5.94 is 73.2% above this benchmark. While the company's 10-year median is 8.38 vs. the industry median of 3.43, Instituto Rosenbusch has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.43, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Instituto Rosenbusch's current OCF Yield % of 5.94 is 73.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Instituto Rosenbusch and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Instituto Rosenbusch's current OCF Yield % is 5.94, which is 29% below median its own 10-year median of 8.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Instituto Rosenbusch stock overvalued right now?
Based on GuruFocus' analysis, Instituto Rosenbusch (BUE:ROSE) is currently considered Significantly Overvalued. The stock's GF Value™ is ARS61.89, compared to a current price of ARS158.00 — trading 155.3% above its estimated fair value. The current OCF Yield % is 5.94, which is 29% below median its 10-year median of 8.38 and 73.2% above the Drug Manufacturers industry median of 3.43. Instituto Rosenbusch's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Instituto Rosenbusch (BUE:ROSE), the current OCF Yield % is 5.94 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Instituto Rosenbusch (BUE:ROSE) Overvalued in 2026?
Based on GuruFocus' analysis, Instituto Rosenbusch stock appears to be overvalued.
The current stock price of ARS158.00 is trading 155.3% above its estimated GF Value™ of ARS61.89.
GuruFocus considers Instituto Rosenbusch to be Significantly Overvalued.
Key valuation signals for BUE:ROSE:
OCF Yield %: 5.94 (29% below median its 10-year median of 8.38)
GF Value™: ARS61.89 vs. price of ARS158.00 (155.3% above fair value)
Industry Position: 73.2% above the Drug Manufacturers median (#360 of 1007)
No single metric tells the full story. See the BUE:ROSE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.
37GF Score
Get the complete analysis for BUE:ROSE
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUE:ROSE has been successfully added to your 
